Cash flow Lotus Pharmaceutical Co., Ltd.

Equities

1795

TW0001795003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
270.50 ^TWD	-2.70%		-1.28%	-0.55%

09-06	Lotus Pharmaceutical Board to Acquire Product Rights of Vietnamese Firm	MT
09-05	Lotus Pharmaceutical Co., Ltd. agreed to acquire Intellectual Property rights of Alpha Choay from Sanofi Vietnam Shareholding Company for $50 million.	CI

5d506.pFn84XSj1fwmZmWsrrk9LpWvQiKaVpSqxuv4qHB9yHY.83SYlAXMoptANSuZ6PVuWsHjcmPOA97N96SqmQkskjyTbp_VHdStuBIgLA

Published financial data: LOTUS PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	9.17B	10.73B	12.65B	14.63B	16.96B
Total Revenues	9.17B	10.73B	12.65B	14.63B	16.96B
Cost of Goods Sold, Total	4.93B	6.13B	7.01B	6.83B	7.57B
Gross Profit	4.25B	4.6B	5.64B	7.81B	9.38B
Selling General & Admin Expenses, Total	2.46B	2.47B	2.7B	3.14B	3.76B
Provision for Bad Debts	467K	-664K	34.24M	-3.33M	-4.04M
R&D Expenses	468M	395M	374M	419M	541M
Other Operating Expenses, Total	2.93B	2.87B	3.11B	3.56B	4.3B
Operating Income	1.32B	1.73B	2.53B	4.25B	5.08B
Interest Expense, Total	-339M	-334M	-267M	-356M	-534M
Interest And Investment Income	12.08M	3.76M	5.34M	3.51M	31.55M
Net Interest Expenses	-327M	-330M	-261M	-353M	-502M
Income (Loss) On Equity Invest.	-681K	3.78M	-	-	-
Currency Exchange Gains (Loss)	74.99M	40.45M	-119M	-81.22M	91.67M
Other Non Operating Income (Expenses)	25.14M	19.92M	1.78M	-10.31M	23.94M
EBT, Excl. Unusual Items	1.09B	1.46B	2.15B	3.81B	4.7B
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	287M	715M
Gain (Loss) On Sale Of Assets	-9.45M	-4.68M	-3.2M	2.52M	-24.74M
Asset Writedown	-209M	-117M	-233M	-138M	-179M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-40.31M	-43.42M	-16M	-104M
EBT, Incl. Unusual Items	876M	1.3B	1.87B	3.94B	5.1B
Income Tax Expense	198M	275M	467M	919M	997M
Earnings From Continuing Operations	678M	1.03B	1.4B	3.02B	4.11B
Net Income to Company	678M	1.03B	1.4B	3.02B	4.11B
Minority Interest	-15.48M	-424K	-	-	-
Net Income - (IS)	663M	1.03B	1.4B	3.02B	4.11B
Net Income to Common Incl Extra Items	663M	1.03B	1.4B	3.02B	4.11B
Net Income to Common Excl. Extra Items	663M	1.03B	1.4B	3.02B	4.11B
Per Share Items
Net EPS - Basic	2.74	4.22	5.5	11.59	15.72
Basic EPS - Continuing Operations	2.74	4.22	5.5	11.59	15.72
Basic Weighted Average Shares Outstanding	242M	243M	255M	261M	261M
Net EPS - Diluted	2.74	4.22	5.47	11.54	15.67
Diluted EPS - Continuing Operations	2.74	4.22	5.47	11.54	15.67
Diluted Weighted Average Shares Outstanding	242M	243M	257M	262M	262M
Normalized Basic EPS	2.76	3.76	5.27	9.13	11.23
Normalized Diluted EPS	2.76	3.76	5.23	9.09	11.2
Dividend Per Share	-	0.35	1.93	3.46	4.65
Payout Ratio	-	-	6.56	16.75	22.07
Supplemental Items
EBITDA	1.74B	2.35B	3.2B	5.09B	6.17B
EBITA	1.56B	2.18B	3.04B	4.92B	5.98B
EBIT	1.32B	1.73B	2.53B	4.25B	5.08B
EBITDAR	-	-	3.21B	5.11B	6.18B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	22.61	21.09	24.95	23.34	19.54
Total Current Taxes	101M	250M	277M	883M	737M
Total Deferred Taxes	97.5M	24.51M	190M	36.06M	261M
Normalized Net Income	669M	915M	1.34B	2.38B	2.93B
Interest on Long-Term Debt	9.08M	7.92M	7.05M	6.01M	11.9M
Non-Cash Pension Expense	15.7M	10.13M	13.14M	13.47M	17.28M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.67B	1.57B	1.8B	2.09B	2.54B
General and Administrative Expenses	787M	905M	906M	1.05B	1.22B
Research And Development Expense From Footnotes	554M	505M	596M	520M	721M
Net Rental Expense, Total	-	-	9.25M	13.15M	12.71M
Imputed Operating Lease Interest Expense	-	-	2.87M	4.72M	5.3M
Imputed Operating Lease Depreciation	-	-	6.39M	8.42M	7.42M
Stock-Based Comp., Other (Total)	-	31.22M	57.66M	39.41M	106M
Total Stock-Based Compensation	-	31.22M	57.66M	39.41M	106M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	1.12B	1.49B	1.61B	1.98B	1.77B
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	1.12B	1.49B	1.61B	1.98B	1.77B
Accounts Receivable, Total	2.2B	2.75B	3.27B	4.65B	6.38B
Other Receivables	150M	53.19M	142M	276M	233M
Notes Receivable	-	-	-	-	-
Total Receivables	2.35B	2.8B	3.41B	4.93B	6.62B
Inventory	1.32B	2.21B	3.07B	3.33B	3.78B
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	671M	285M	247M	420M	489M
Total Current Assets	5.47B	6.78B	8.33B	10.66B	12.65B
Gross Property Plant And Equipment	3.48B	3.8B	4.32B	5.02B	5.55B
Accumulated Depreciation	-1.44B	-1.49B	-1.68B	-1.87B	-2.04B
Net Property Plant And Equipment	2.04B	2.31B	2.64B	3.15B	3.51B
Long-term Investments	458M	413M	302M	2.16B	3.05B
Goodwill	5.91B	5.9B	5.59B	5.67B	5.67B
Other Intangibles, Total	2.09B	3.18B	2.97B	5.91B	5.49B
Accounts Receivable Long-Term	-	-	-	-	153M
Deferred Tax Assets Long-Term	379M	365M	311M	390M	412M
Deferred Charges Long-Term	809M	654M	892M	1.41B	1.88B
Other Long-Term Assets, Total	763M	161M	185M	185M	180M
Total Assets	17.92B	19.75B	21.22B	29.53B	32.99B
Liabilities
Accounts Payable, Total	882M	1.73B	748M	1.4B	671M
Accrued Expenses, Total	50.57M	2.46M	932K	959K	3.87M
Short-term Borrowings	460M	410M	1.38B	156M	510M
Current Portion of Long-Term Debt	579M	1.36B	795M	59.95M	1.3B
Current Portion of Leases	54.73M	40.43M	62.47M	58.99M	70.24M
Current Income Taxes Payable	49.65M	227M	280M	731M	437M
Unearned Revenue Current, Total	65.05M	132M	132M	183M	133M
Other Current Liabilities	818M	981M	931M	3.3B	1.4B
Total Current Liabilities	2.96B	4.88B	4.33B	5.89B	4.52B
Long-Term Debt	5.98B	4.95B	4.67B	8.6B	9.52B
Long-Term Leases	115M	76.58M	43.41M	46.82M	182M
Unearned Revenue Non Current	104M	112M	85.96M	65.92M	45.33M
Pension & Other Post Retirement Benefits	565M	587M	503M	372M	503M
Deferred Tax Liability Non Current	172M	145M	304M	448M	721M
Other Non Current Liabilities	281M	257M	224M	236M	162M
Total Liabilities	10.17B	11.01B	10.15B	15.66B	15.66B
Common Stock, Total	2.43B	2.45B	2.63B	2.63B	2.65B
Additional Paid In Capital	6.59B	6.8B	8.04B	7.53B	7.13B
Retained Earnings	-653M	354M	1.7B	4.82B	8.9B
Treasury Stock	-	-	-57.75M	-57.35M	-51.1M
Comprehensive Income and Other	-624M	-861M	-1.24B	-1.06B	-1.3B
Total Common Equity	7.74B	8.75B	11.07B	13.87B	17.33B
Minority Interest	1.81M	-	-	-	-
Total Equity	7.74B	8.75B	11.07B	13.87B	17.33B
Total Liabilities And Equity	17.92B	19.75B	21.22B	29.53B	32.99B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	243M	245M	262M	262M	264M
ECS Total Common Shares Outstanding	243M	245M	262M	262M	264M
Book Value / Share	31.85	35.64	42.21	52.92	65.54
Tangible Book Value	-256M	-327M	2.51B	2.29B	6.18B
Tangible Book Value Per Share	-1.05	-1.33	9.58	8.74	23.36
Total Debt	7.19B	6.83B	6.94B	8.92B	11.58B
Net Debt	6.06B	5.34B	5.34B	6.93B	9.81B
Debt Equivalent of Unfunded Proj. Benefit Obligation	547M	570M	485M	353M	481M
Debt Equivalent Oper. Leases	-	-	74.02M	105M	102M
Minority Interest, Total (Incl. Fin. Div)	1.81M	-	-	-	-
Equity Method Investments, Total	8.35M	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	389M	624M	1.65B	1.43B	1.34B
Inventories - Work In Process, Total	142M	518M	585M	505M	479M
Inventories - Finished Goods, Total	793M	1.07B	840M	1.39B	1.96B
Land - (BS)	656M	654M	615M	622M	623M
Buildings, Total	983M	1.01B	1.31B	1.38B	1.89B
Machinery, Total	1.24B	1.32B	1.41B	1.55B	1.83B
Full Time Employees	1.1K	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	18.02M	17.17M	49.55M	46.43M	41.85M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	663M	1.03B	1.4B	3.02B	4.11B
Depreciation & Amortization - CF	255M	243M	240M	256M	307M
Amortization of Goodwill and Intangible Assets - (CF)	236M	455M	509M	671M	894M
Depreciation & Amortization, Total	490M	698M	749M	927M	1.2B
Amortization of Deferred Charges, Total - (CF)	96.44M	11.74M	10.62M	9.91M	10.23M
(Gain) Loss From Sale Of Asset	9.45M	4.68M	3.2M	-2.52M	24.74M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-287M	-715M
Asset Writedown & Restructuring Costs	211M	128M	235M	137M	179M
(Income) Loss On Equity Investments - (CF)	681K	-3.78M	-	-	-
Stock-Based Compensation (CF)	-	31.22M	57.66M	39.41M	106M
Provision and Write-off of Bad Debts	467K	-664K	34.24M	-3.33M	-4.04M
Other Operating Activities, Total	165M	352M	460M	788M	144M
Change in Trading Asset Securities	-	-	-	-	-
Change In Accounts Receivable	-1.11B	-496M	-633M	-1.37B	-1.66B
Change In Inventories	-286M	-1.1B	-1.13B	-313M	-623M
Change In Accounts Payable	191M	996M	-981M	648M	-660M
Change in Unearned Revenues	671K	72.51M	-9.74M	20M	-69.33M
Change in Other Net Operating Assets	-131M	226M	-83.62M	109M	-421M
Cash from Operations	303M	1.95B	120M	3.72B	1.61B
Capital Expenditure	-333M	-414M	-573M	-577M	-411M
Sale of Property, Plant, and Equipment	32.89M	45K	110K	9.38M	1.25M
Cash Acquisitions	-	77.38M	-	-	-
Sale (Purchase) of Intangible assets	-769M	-1.58B	-1.04B	-2.49B	-2.86B
Investment in Marketable and Equity Securities, Total	-616M	12.13M	-	-1.58B	-
Other Investing Activities, Total	-702M	783M	38.8M	-13.38M	24.48M
Cash from Investing	-2.39B	-1.12B	-1.58B	-4.66B	-3.25B
Short Term Debt Issued, Total	170M	-	1.29B	1.43B	1.22B
Long-Term Debt Issued, Total	3.08B	5.55B	5.06B	6.25B	20.48B
Total Debt Issued	3.25B	5.55B	6.35B	7.68B	21.69B
Short Term Debt Repaid, Total	-20M	-50M	-871M	-2.1B	-862M
Long-Term Debt Repaid, Total	-908M	-6.05B	-5.64B	-3.26B	-18.52B
Total Debt Repaid	-928M	-6.1B	-6.51B	-5.36B	-19.38B
Issuance of Common Stock	617M	-	1.41B	-	598K
Repurchase of Common Stock	-	-	-57.35M	-	-
Common Dividends Paid	-	-	-92M	-506M	-906M
Common & Preferred Stock Dividends Paid	-	-	-92M	-506M	-906M
Other Financing Activities, Total	-712M	1.35M	558M	-558M	-
Cash from Financing	2.23B	-545M	1.66B	1.26B	1.4B
Foreign Exchange Rate Adjustments	-38.12M	-66.4M	-89.52M	52.89M	19.91M
Net Change in Cash	101M	212M	116M	378M	-213M
Supplemental Items
Cash Interest Paid	282M	393M	228M	291M	446M
Cash Income Tax Paid (Refund)	110M	89.65M	260M	445M	1.04B
Levered Free Cash Flow	-1.34B	-162M	-1.8B	1.92B	-4.3B
Unlevered Free Cash Flow	-1.13B	46.12M	-1.63B	2.14B	-3.96B
Change In Net Working Capital	1.44B	-222M	2.42B	-1.58B	5.18B
Net Debt Issued / Repaid	2.32B	-547M	-159M	2.33B	2.31B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	5.04	5.7	7.71	10.47	10.16
Return on Total Capital	6.03	7.06	9.41	13.02	12.29
Return On Equity %	8.79	12.48	14.17	24.23	26.32
Return on Common Equity	8.86	12.46	14.17	24.23	26.32
Margin Analysis
Gross Profit Margin %	46.3	42.84	44.59	53.35	55.34
SG&A Margin	26.79	23.05	21.37	21.47	22.2
EBITDA Margin %